SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-032264
Filing Date
2021-06-09
Accepted
2021-06-09 16:05:39
Documents
14
Period of Report
2021-06-09
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K hsto-8k_20210609.htm   iXBRL 8-K 37407
2 EX-99.1 hsto-ex991_6.htm EX-99.1 16465
3 GRAPHIC gufmy2zru5ty000001.jpg GRAPHIC 3598
  Complete submission text file 0001564590-21-032264.txt   194205

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA hsto-20210609.xsd EX-101.SCH 5788
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE hsto-20210609_lab.xml EX-101.LAB 19478
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hsto-20210609_pre.xml EX-101.PRE 11639
7 EXTRACTED XBRL INSTANCE DOCUMENT hsto-8k_20210609_htm.xml XML 3553
Mailing Address 10655 SORRENTO VALLEY ROAD SUITE 200 San Diego CA 92121
Business Address 10655 SORRENTO VALLEY ROAD SUITE 200 San Diego CA 92121 (858) 526-3100
Histogen Inc. (Filer) CIK: 0001383701 (see all company filings)

IRS No.: 203183915 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36003 | Film No.: 211005193
SIC: 2834 Pharmaceutical Preparations